|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | PD 0332991 | Storage (From the date of receipt) |
3 years -20°C powder |
| 化学式 | C24H29N7O2 |
|||
| 分子量 | 447.53 | CAS No. | 571190-30-2 | |
| Solubility (25°C)* | 体外 | DMSO | Insoluble | |
| Water | Insoluble | |||
| Ethanol | Insoluble | |||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
||||
| 製品説明 | Palbociclib (PD 0332991)は、サイクリン依存性キナーゼ4 (Cdk4)およびCdk6の非常に特異的な阻害剤であり、IC50値はそれぞれ11 nMおよび16 nMです。本製品は溶解度が低いため、動物生体内実験には利用できますが、細胞実験には慎重にご選択ください。 |
|---|
| 細胞アッセイ | 細胞株 | BT474 and MDA-MB-361 tumor cell lines |
|---|---|---|
| 濃度 | 0-15 μM | |
| 反応時間 | 72 h | |
| 実験の流れ | Cell viability is measured by Cell Titer Glo assay after 72 hours of treatment with vehicle or drugs. For all experiments with fulvestrant, cells are grown in estrogen free conditions, and estradiol is added to a final concentration of 10-8 M prior to drug treatment. |
|
| 動物実験 | 動物モデル | NCG mice injected with MDA-MB-361 cells |
| 投薬量 | 50mg/kg | |
| 投与方法 | o.g. |
|
| Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial [ Nat Commun, 2026, 17(1):949] | PubMed: 41593097 |
| Tumor-suppressive role of miR-216b impacts cell cycle regulation in high-grade glioma [ Acta Neuropathol Commun, 2026, 14(1)81] | PubMed: 41943043 |
| Basroparib inhibits YAP-driven cancers by stabilizing angiomotin [ Mol Oncol, 2026, 10.1002/1878-0261.70209] | PubMed: 41569232 |
| Exploration of Therapeutic Targets Using CDK4 Inhibitors for Head and Neck Mucosal Melanoma [ J OTOLARYNGOL-HEAD N, 2026, 174(3):784-791] | PubMed: 41568999 |
| CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancer [ Signal Transduct Target Ther, 2025, 10(1):363] | PubMed: 41193441 |
| Fasting-mimicking diet potentiates anti-tumor effects of CDK4/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling [ Drug Resist Updat, 2025, 78:101161] | PubMed: 39499997 |
| High-throughput investigation of cyclin docking interactions reveals the complexity of motif binding determinants [ Nat Commun, 2025, 16(1):7622] | PubMed: 40817109 |
| Combined therapy with DR5-targeting antibody-drug conjugate and CDK inhibitors as a strategy for advanced colorectal cancer [ Cell Rep Med, 2025, S2666-3791(25)00231-9] | PubMed: 40449480 |
| Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studies [ Cell Rep Med, 2025, 6(2):101964] | PubMed: 39933527 |
| MRN-CtIP, EXO1, and DNA2-WRN/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand cleavage [ Genes Dev, 2025, 39(9-10):582-602] | PubMed: 40127955 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。